Skip to content

Prospective, randomized, double-blind, parallel, placebo-controlled, multicenter clinical studies of acupuncture point patches for the treatment of Hashimoto's thyroiditis

Acupuncture point patches are suitable for clinical studies of medical evidence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005620
Enrollment
Unknown
Registered
2022-02-07
Start date
2022-02-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto's thyroiditis

Interventions

Control group:Placebo patch + herbal powder placebo acupoint patch
Experimental group:Anti-swelling and pain-relieving patch + Chinese medicine powder acupuncture point patch

Sponsors

The Affiliated Hospital of Shandong University of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria of Hashimoto thyroiditis and Western medicine; 2. Young women aged 18 to 45; 3. Laboratory tests of thyroid function show that TPOAb (normal value: 0~34IU/ml) and TgAb (normal value: 0~115IU/mL) are elevated, while FT3 (normal value: 3.1~6.8pmol/L), FT4 (normal value: 12~22pmol/L) and TSH (normal value: 0.270~4.20mIU/L) levels are normal; 4. Informed consent and signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. Exclude thyroid cancer and thyroid surgery; 2. The clinical data and related examination results are incomplete; 3. Those who have their own original diabetes, hyperlipidemia and other metabolic diseases; 4. Those who need conventional medication treatment with other diseases; 5. Those who have skin trauma, ulcers, infections or scars at the patch site and are allergic to the patch; 6. Other factors can not cooperate with the investigator. Note: Any one or more of the above items should be excluded and cannot be selected.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy;

Secondary

MeasureTime frame
TCM Syndrome Points;electrocardiogram;Thyroid hormone levels;Liver and kidney function;Adverse reactions/events;Poop routine;Urinalysis;Thyroid acoustic performance and size;Blood routine;

Countries

China

Contacts

Public ContactLi Jingwei
71000395@sdutcm.edu.cn13668813180

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026